NASDAQ Health Care Index (IXHC) Companies by Market Cap
The NASDAQ Health Care Index (IXHC) tracks 976 constituent companies with a combined market cap of $2.52 Trillion, covering the largest publicly traded companies in USA. This ranking lists all IXHC index holdings ordered by market capitalization — from the largest index heavyweights to smaller constituents. Updated daily with live market data.
Total Market Cap (USD)
$2.52 Trillion
Constituent Companies
976
Index Country
USA
| Rank | Company | Weight (%) | Market Cap (USD) | Sector | Industry | Price | 24h Change |
|---|---|---|---|---|---|---|---|
| 401 |
Fennec Pharmaceuticals Inc
NASDAQ:FENC |
% | $311.94 Million | Healthcare | Biotechnology | $10.49 | +1.75% |
| 402 |
Goodrx Holdings Inc
NASDAQ:GDRX |
% | $311.13 Million | Healthcare | Health Information Services | $2.95 | +0.34% |
| 403 |
Tenax Therapeutics Inc
NASDAQ:TENX |
% | $308.02 Million | Healthcare | Biotechnology | $17.55 | -4.20% |
| 404 |
Airsculpt Technologies Inc
NASDAQ:AIRS |
% | $305.46 Million | Healthcare | Medical Care Facilities | $4.33 | +0.00% |
| 405 |
SBC Medical Group Holdings Incorporated
NASDAQ:SBC |
% | $304.65 Million | Industrials | Consulting Services | $2.97 | -0.34% |
| 406 |
Organogenesis Holdings Inc
NASDAQ:ORGO |
% | $304.59 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $2.40 | -2.44% |
| 407 |
Scpharmaceuticals Inc
NASDAQ:SCPH |
% | $304.36 Million | Healthcare | Biotechnology | $5.67 | +0.00% |
| 408 |
Rezolute Inc
NASDAQ:RZLT |
% | $303.36 Million | Healthcare | Biotechnology | $4.75 | -7.41% |
| 409 |
908 Devices Inc
NASDAQ:MASS |
% | $299.86 Million | Healthcare | Medical Devices | $8.10 | -0.37% |
| 410 |
Editas Medicine Inc
NASDAQ:EDIT |
% | $299.59 Million | Healthcare | Biotechnology | $3.26 | -1.21% |
| 411 |
Eledon Pharmaceuticals Inc
NASDAQ:ELDN |
% | $297.17 Million | Healthcare | Biotechnology | $3.85 | -6.78% |
| 412 |
Greenwich Lifesciences Inc
NASDAQ:GLSI |
% | $290.63 Million | Healthcare | Biotechnology | $19.80 | +1.18% |
| 413 |
Foghorn Therapeutics Inc
NASDAQ:FHTX |
% | $288.22 Million | Healthcare | Biotechnology | $5.95 | -1.00% |
| 414 |
Neumora Therapeutics, Inc.
NASDAQ:NMRA |
% | $285.50 Million | Healthcare | Biotechnology | $1.68 | +1.82% |
| 415 |
Sight Sciences Inc
NASDAQ:SGHT |
% | $281.28 Million | Healthcare | Medical Devices | $5.32 | +1.14% |
| 416 |
Opus Genetics, Inc.
NASDAQ:IRD |
% | $279.90 Million | Healthcare | Biotechnology | $3.92 | -2.49% |
| 417 |
TruBridge Inc.
NASDAQ:TBRG |
% | $277.27 Million | Healthcare | Health Information Services | $26.24 | +0.00% |
| 418 |
Prenetics Global Ltd
NASDAQ:PRE |
% | $272.32 Million | Healthcare | Diagnostics & Research | $17.86 | +0.06% |
| 419 |
Niagen Bioscience, Inc.
NASDAQ:NAGE |
% | $270.54 Million | Healthcare | Biotechnology | $3.39 | -2.87% |
| 420 |
Surrozen Inc
NASDAQ:SRZN |
% | $267.15 Million | Healthcare | Biotechnology | $23.19 | -1.32% |
| 421 |
2Seventy Bio Inc
NASDAQ:TSVT |
% | $266.14 Million | Healthcare | Biotechnology | $5.00 | +0.00% |
| 422 |
Entrada Therapeutics Inc
NASDAQ:TRDA |
% | $264.48 Million | Healthcare | Biotechnology | $6.92 | -6.49% |
| 423 |
SAB Biotherapeutics Inc
NASDAQ:SABS |
% | $261.43 Million | Healthcare | Biotechnology | $3.82 | -3.54% |
| 424 |
Inozyme Pharma Inc
NASDAQ:INZY |
% | $258.25 Million | Healthcare | Biotechnology | $4.00 | +0.00% |
| 425 |
SIGA Technologies Inc
NASDAQ:SIGA |
% | $257.49 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $3.59 | +2.57% |
| 426 |
ProKidney Corp.
NASDAQ:PROK |
% | $249.90 Million | Healthcare | Biotechnology | $1.76 | -2.22% |
| 427 |
Genfit S.A.
NASDAQ:GNFT |
% | $244.43 Million | Healthcare | Biotechnology | $5.97 | +0.00% |
| 428 |
Shattuck Labs Inc
NASDAQ:STTK |
% | $244.26 Million | Healthcare | Biotechnology | $6.64 | -5.55% |
| 429 |
Zura Bio Limited Class A Ordinary Shares
NASDAQ:ZURA |
% | $243.84 Million | Healthcare | Biotechnology | $5.11 | -7.26% |
| 430 |
Adagene Inc
NASDAQ:ADAG |
% | $243.81 Million | Healthcare | Biotechnology | $3.94 | +2.34% |
| 431 |
Monogram Orthopaedics Inc. Common Stock
NASDAQ:MGRM |
% | $243.79 Million | Healthcare | Medical Devices | $6.00 | -1.80% |
| 432 |
AC Immune Ltd
NASDAQ:ACIU |
% | $243.24 Million | Healthcare | Biotechnology | $2.39 | -8.08% |
| 433 |
Third Harmonic Bio Inc.
NASDAQ:THRD |
% | $242.79 Million | Healthcare | Biotechnology | $5.38 | +0.00% |
| 434 |
Sol Gel Technologies Ltd
NASDAQ:SLGL |
% | $241.74 Million | Healthcare | Biotechnology | $73.95 | -3.16% |
| 435 |
Orchestra BioMed Holdings Inc.
NASDAQ:OBIO |
% | $238.92 Million | Healthcare | Biotechnology | $3.99 | +1.79% |
| 436 |
Protara Therapeutics Inc
NASDAQ:TARA |
% | $236.06 Million | Healthcare | Biotechnology | $4.32 | +2.86% |
| 437 |
Anavex Life Sciences Corp
NASDAQ:AVXL |
% | $231.68 Million | Healthcare | Biotechnology | $2.50 | -7.41% |
| 438 |
Nuvectis Pharma Inc
NASDAQ:NVCT |
% | $231.56 Million | Healthcare | Biotechnology | $18.35 | -3.37% |
| 439 |
Nautilus Biotechnology Inc
NASDAQ:NAUT |
% | $231.14 Million | Healthcare | Biotechnology | $1.89 | -0.53% |
| 440 |
Fulcrum Therapeutics Inc
NASDAQ:FULC |
% | $230.90 Million | Healthcare | Biotechnology | $3.50 | -2.51% |
| 441 |
Coherus BioSciences Inc
NASDAQ:CHRS |
% | $230.83 Million | Healthcare | Biotechnology | $1.54 | -5.52% |
| 442 |
Invivyd Inc.
NASDAQ:IVVD |
% | $230.68 Million | Healthcare | Biotechnology | $0.78 | -2.58% |
| 443 |
ACELYRIN, INC. Common Stock
NASDAQ:SLRN |
% | $229.17 Million | Healthcare | Biotechnology | $2.27 | +0.00% |
| 444 |
Treace Medical Concepts Inc
NASDAQ:TMCI |
% | $227.70 Million | Healthcare | Medical Devices | $4.32 | -7.30% |
| 445 |
Precision BioSciences Inc
NASDAQ:DTIL |
% | $226.03 Million | Healthcare | Biotechnology | $8.76 | -4.37% |
| 446 |
CAMP4 THERAPEUTICS CORPORATION
NASDAQ:CAMP |
% | $224.84 Million | Healthcare | Biotechnology | $4.33 | -0.23% |
| 447 |
Bicycle Therapeutics Ltd
NASDAQ:BCYC |
% | $220.19 Million | Healthcare | Biotechnology | $4.41 | +5.50% |
| 448 |
MacroGenics Inc
NASDAQ:MGNX |
% | $218.65 Million | Healthcare | Biotechnology | $4.33 | -5.25% |
| 449 |
Cellectis SA
NASDAQ:CLLS |
% | $217.37 Million | Healthcare | Biotechnology | $2.99 | -5.77% |
| 450 |
Utah Medical Products Inc
NASDAQ:UTMD |
% | $216.39 Million | Healthcare | Medical Instruments & Supplies | $67.96 | -0.61% |
Complete list of all companies in the IXHC index ranked by market capitalization. Track index constituent performance and market values. View all indices